Bush Institute Global Health Initiative

Saving women's lives from cervical cancer in sub-Saharan Africa

The global health community has made significant progress in reducing the number of deaths from diseases like HIV/AIDS. But the work is not complete.

Go Further is an innovative partnership that leverages public and private investments with the goal of significantly reducing cervical cancer deaths among HIV-positive women in Sub-Saharan Africa within a generation.

The U.S. President's Emergency Plan for AIDS Relief (PEPFAR) has saved millions of lives from HIV/AIDS. But women living HIV are five times more likely to develop cervical cancer — and are dying from a preventable and treatable disease.

Led by the Bush Institute, PEPFAR, UNAIDS, and Merck, Go Further increases access to the HPV vaccine to prevent cervical cancer, expands the availability of vital cervical cancer screening, and provides treatment for those most vulnerable to developing cervical cancer. 

Since inception, the Bush Institute's Global Health Initiative has: 

  • Heightened awareness of cervical cancer on the continent of Africa
  • Partnered with African governments and partners to establish national policy frameworks on cancer prevention, early detection, and treatment
  • Developed tools for measuring impact across cervical cancer programs
  • Leveraged support for a trial to determine the safety and efficacy of two versus three doses of the 9-valent HPV vaccine in women living with HIV
  • Hosted meetings and roundtables with stakeholders to increase support and political will for a sustained, strong response to HIV/AIDS, prioritize cervical cancer services for women living with HIV, and foster coordination along the continuum of cervical cancer care

Related Content

Global Health Initiative Team